Edahiro Yoko

Research field (1)： Hematology and oncology

Research theme for competitive and other funds (1)：

2019 - 2022 Identification of the mechanism of anti-tumor effect of IFN-alpha against malignant stem cells using iPS cells

Papers (68)：

Yoko Edahiro, Keita Kirito, Akihiko Gotoh, Katsuto Takenaka, Yuka Sugimoto, Norio Komatsu, Kazuya Shimoda. A cross-sectional survey of symptoms and daily living among patients with polycythemia vera and their treating physicians in Japan. Hematology (Amsterdam, Netherlands). 2023. 28. 1. 2227817-2227817
Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu. MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan. Hematology (Amsterdam, Netherlands). 2023. 28. 1. 2229131-2229131
Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Soji Morishita, Shuichi Shirane, Tadaaki Inano, Chiho Furuya, Michiaki Koike, Masaaki Noguchi, Kensuke Usuki, et al. Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. International journal of hematology. 2023. 118. 1. 47-53
Koji Tsuchiya, Konobu Kimura, Tomohiko Ai, Takamasa Yamamoto, Kaori Nagasaka, Hiroyuki Takemura, Yoko Edahiro, Kaori Saito, Yuki Horiuchi, Shigeki Misawa, et al. Evaluation of bone marrow aspirates using the automated hematology analyzer Sysmex XN-3000. International journal of laboratory hematology. 2023
Chang Liu, Misa Imai, Yoko Edahiro, Shuichi Mano, Hiraku Takei, Mai Nudejima, Akira Kurose, Soji Morishita, Miki Ando, Satoshi Tsuneda, et al. Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms. Experimental Hematology. 2023. 118. 12-20

ｍore...

MISC (45)：

橋本由徳, 枝廣陽子, 伊藤量基, 後藤明彦, 中前美佳, 木村文彦, 小池道明, 桐戸敬太, 和田秀穂, 臼杵憲祐, et al. A nationwide survey on Japanese patients with essential thrombocythemia: JSH-MPN-R18 study(和訳中). 日本血液学会学術集会. 2021. 83回. OS3-3
森下総司, 安田肇, 山脇紗耶, 川路英哉, 伊藤昌可, 枝廣陽子, 今井美沙, 向後泰司, 常田聡, 大坂顯通, et al. 骨髄増殖性腫瘍の新規汎用診断マーカー. 日本血液学会学術集会抄録(Web). 2020. 82nd
枝廣陽子, 小松則夫. 骨髄線維症患者に対するruxolitinibの有効性と安全性単施設での後方視的検討. 臨床血液. 2019. 60. 7. 755-760
荒木真理人, 楊印杰, 増渕菜弥, 林英里奈, 水上喜久, 木原慶彦, 今井美沙, 弘中由美, ぬで島麻衣, 枝廣陽子, et al. MPN関連 calreticulin変異による骨髄増殖性腫瘍発症の分子メカニズム. Cytometry Research. 2019. 29. Suppl. 40-40
枝廣陽子, 竹井拓, Liu Chang, ぬで島麻衣, 森下総司, 大坂顯通, 荒木真理人, 小松則夫. ヒト造血幹細胞分化に対するJAK2V617Fアレルの負荷の影響(The impact of allelic burden of JAK2V617F on human hematopoietic cell differentiation). Cytometry Research. 2019. 29. Suppl. 68-68

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page